(CNXC) Concentrix - Overview
Sector: Technology | Industry: Information Technology Services | Exchange: NASDAQ (USA) | Market Cap: 1.607m USD | Total Return: -52.6% in 12m
Avg Turnover: 35.6M
EPS Trend: 24.4%
Qual. Beats: 0
Rev. Trend: 91.2%
Qual. Beats: 0
Warnings
Altman Z'' 0.52 < 1.0 - financial distress zone
Tailwinds
No distinct edge detected
Concentrix Corporation (CNXC) is a global provider of customer experience (CX) solutions, specializing in digital transformation, process optimization, and technology-driven engagement. The company manages end-to-end customer lifecycles by integrating front-office support with back-office automation and data analytics across diverse sectors, including technology, banking, and healthcare.
Operating within the Data Processing & Outsourced Services sub-industry, Concentrix utilizes a Business Process Outsourcing (BPO) model that increasingly relies on generative AI and agentic assistants to automate high-volume interactions. This shift toward non-human engagement allows the firm to scale operations while reducing the labor intensity traditionally associated with global service centers.
For a deeper dive into the companys valuation metrics and historical performance, you may want to explore the data available on ValueRay.
The company’s service suite extends beyond basic support to include performance marketing, financial compliance, and enterprise intelligence. Founded in 2004 and headquartered in California, Concentrix maintains a global footprint to support multinational clients in navigating complex digital operations and customer loyalty strategies.
- Generative AI integration reduces labor costs while improving service delivery margins
- Global enterprise digital transformation spending dictates organic revenue growth trajectory
- Concentrix and Webhelp merger integration impacts operational leverage and debt reduction
- Wage inflation in offshore delivery centers pressures global gross profit margins
- Shift toward automated self-service solutions offsets traditional voice-based customer support volume
| Net Income: -1.33b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.05 > 0.02 and ΔFCF/TA 0.48 > 1.0 |
| NWC/Revenue: 4.68% < 20% (prev 12.19%; Δ -7.51% < -1%) |
| CFO/TA 0.07 > 3% & CFO 722.3m > Net Income -1.33b |
| Net Debt (4.52b) to EBITDA (1.22b): 3.71 < 3 |
| Current Ratio: 1.18 > 1.5 & < 3 |
| Outstanding Shares: last quarter (61.3m) vs 12m ago -4.32% < -2% |
| Gross Margin: 32.81% > 18% (prev 0.36%; Δ 3.24k% > 0.5%) |
| Asset Turnover: 88.21% > 50% (prev 80.61%; Δ 7.60% > 0%) |
| Interest Coverage Ratio: 1.91 > 6 (EBITDA TTM 1.22b / Interest Expense TTM 292.7m) |
| A: 0.04 (Total Current Assets 3.04b - Total Current Liabilities 2.58b) / Total Assets 10.7b |
| B: -0.02 (Retained Earnings -178.6m / Total Assets 10.7b) |
| C: 0.05 (EBIT TTM 559.2m / Avg Total Assets 11.3b) |
| D: -0.05 (Book Value of Equity -369.6m / Total Liabilities 7.89b) |
| Altman-Z'' = 0.52 = B |
| DSRI: 0.97 (Receivables 2.04b/2.01b, Revenue 9.95b/9.59b) |
| GMI: 1.10 (GM 32.81% / 35.96%) |
| AQI: 0.93 (AQ_t 0.65 / AQ_t-1 0.69) |
| SGI: 1.04 (Revenue 9.95b / 9.59b) |
| TATA: -0.19 (NI -1.33b - CFO 722.3m) / TA 10.7b) |
| Beneish M = -3.17 (Cap -4..+1) = AA |
As of May 25, 2026, the stock is trading at USD 26.34 with a total of 869,467 shares traded.
Over the past week, the price has changed by +9.61%,
over one month by +0.65%,
over three months by -12.26% and
over the past year by -52.55%.
Concentrix has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy CNXC.
- StrongBuy: 2
- Buy: 2
- Hold: 2
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 41.3 | 56.6% |
P/E Forward = 2.2386
P/S = 0.1614
P/B = 0.5765
P/EG = 0.2487
Revenue TTM = 9.95b USD
EBIT TTM = 559.2m USD
EBITDA TTM = 1.22b USD
Long Term Debt = 4.00b USD (from longTermDebt, last quarter)
Short Term Debt = 750.0m USD (from shortTermDebt, last quarter)
Debt = 4.75b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 4.52b USD (calculated: Debt 4.75b - CCE 222.7m)
Enterprise Value = 6.13b USD (1.61b + Debt 4.75b - CCE 222.7m)
Interest Coverage Ratio = 1.91 (Ebit TTM 559.2m / Interest Expense TTM 292.7m)
EV/FCF = 12.65x (Enterprise Value 6.13b / FCF TTM 484.6m)
FCF Yield = 7.91% (FCF TTM 484.6m / Enterprise Value 6.13b)
FCF Margin = 4.87% (FCF TTM 484.6m / Revenue TTM 9.95b)
Net Margin = -13.34% (Net Income TTM -1.33b / Revenue TTM 9.95b)
Gross Margin = 32.81% ((Revenue TTM 9.95b - Cost of Revenue TTM 6.69b) / Revenue TTM)
Gross Margin QoQ = 33.98% (prev 27.92%)
Tobins Q-Ratio = 0.57 (Enterprise Value 6.13b / Total Assets 10.7b)
Interest Expense / Debt = 6.17% (Interest Expense 292.7m / Debt 4.75b)
Taxrate = 24.86% (7.14m / 28.7m)
NOPAT = 420.2m (EBIT 559.2m * (1 - 24.86%))
Current Ratio = 1.18 (Total Current Assets 3.04b / Total Current Liabilities 2.58b)
Debt / Equity = 1.70 (Debt 4.75b / totalStockholderEquity, last quarter 2.79b)
Debt / EBITDA = 3.71 (Net Debt 4.52b / EBITDA 1.22b)
Debt / FCF = 9.33 (Net Debt 4.52b / FCF TTM 484.6m)
Total Stockholder Equity = 3.54b (last 4 quarters mean from totalStockholderEquity)
RoA = -11.76% (Net Income -1.33b / Total Assets 10.7b)
RoE = -35.71% (Net Income TTM -1.33b / Total Stockholder Equity 3.72b)
RoCE = 7.25% (EBIT 559.2m / Capital Employed (Equity 3.72b + L.T.Debt 4.00b))
RoIC = 4.81% (NOPAT 420.2m / Invested Capital 8.73b)
WACC = 6.06% (E(1.61b)/V(6.35b) * Re(10.25%) + D(4.75b)/V(6.35b) * Rd(6.17%) * (1-Tc(0.25)))
Discount Rate = 10.25% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -50.13 | Cagr: 5.57%
[DCF] Terminal Value 75.50% ; FCFF base≈483.7m ; Y1≈487.5m ; Y5≈520.2m
[DCF] Fair Price = 58.38 (EV 8.08b - Net Debt 4.52b = Equity 3.56b / Shares 61.0m; r=8.35% [WACC [floored]]; 5y FCF grow 0.44% → 2.50% )
EPS Correlation: 24.40 | EPS CAGR: 0.50% | SUE: -0.26 | # QB: 0
Revenue Correlation: 91.15 | Revenue CAGR: 18.17% | SUE: 0.79 | # QB: 0
EPS current Quarter (2026-05-31): EPS=2.63 | Chg30d=-3.78% | Revisions=-43% | Analysts=3
EPS next Quarter (2026-08-31): EPS=3.06 | Chg30d=-0.22% | Revisions=+14% | Analysts=3
EPS current Year (2026-11-30): EPS=11.71 | Chg30d=-3.79% | Revisions=-43% | GrowthEPS=+4.4% | GrowthRev=+3.0%
EPS next Year (2027-11-30): EPS=12.84 | Chg30d=-3.61% | Revisions=-33% | GrowthEPS=+9.6% | GrowthRev=+2.4%
[Analyst] Revisions Ratio: -43%